SOD-1 inhibits FAS expression in cortex of APP transgenic mice
- 1 May 2005
- journal article
- Published by Springer Nature in Apoptosis
- Vol. 10 (3) , 499-502
- https://doi.org/10.1007/s10495-005-1879-y
Abstract
Peptides derived from proteolytic processing of the amyloid precursor protein (APP) are important for the pathogenesis of Alzheimer’s disease (AD). In the present study, we found that transgenic mice overexpressing wild-type human APP gene (hAPP/+) displayed a much higher expression of FAS, one of the death receptor subfamily. This FAS overexpression was significantly reduced in the cortex of mice overexpressing both wild-type hAPP gene and wild-type human superoxide dismutase-1 gene (hSOD-1). Moreover hSOD-1 transgenic expression was associated with an increase of Glial fibrillary acidic protein (GFAP) production. This study indicates that SOD-1 overexpression can inhibit FAS expression, which may be beneficial in AD.Keywords
This publication has 25 references indexed in Scilit:
- AATF protects neural cells against oxidative damage induced by amyloid β-peptideNeurobiology of Disease, 2004
- Plasma amyloid β protein 1–42 levels are increased in old Down Syndrome but not in young Down SyndromeNeuroscience Letters, 2003
- Specific uptake of Aβ1-40 in rat brain occurs in astrocyte, but not in microgliaNeuroscience Letters, 2003
- Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and AChTrends in Neurosciences, 2002
- Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative StressJournal of Neurochemistry, 1998
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondriaNeuron, 1995
- Amyloid β Protein (Aβ) in Alzheimeri's Disease BrainJournal of Biological Chemistry, 1995
- A radical hypothesis for neurodegenerationTrends in Neurosciences, 1993
- Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal FluidJournal of Neurochemistry, 1993